Ars Asks: Share your shell and show us your tricked-out terminals!

Exposure therapy to the bash shell brought me to the tipping point, and I jumped ship to the Macintosh side of the house. It ...
ascopubs.org

LEAP-014: An open-label, randomized, phase 3 study of first-line lenvatinib plus pembrolizumab plus chemotherapy in esophageal squamous cell carcinoma.

INTEGRATE IIb: A randomized phase III open label study of regorafenib + nivolumab versus standard chemotherapy in refractory advanced gastroesophageal cancer (AGOC). This is an ASCO Meeting Abstract ...

Military drills on the edge: U.S. and allies test capabilities near Asia's flash points

From drone boats to long-range missiles, the U.S. and its allies tested new military tactics in the Philippines, sharpening ...
ascopubs.org

Nivolumab plus ipilimumab vs sunitinib for first-line treatment of advanced renal cell carcinoma: Final analysis from the phase 3 CheckMate 214 trial.

Combination casdatifan plus cabozantinib expansion cohort of phase 1 ARC-20 study in previously treated patients with clear cell renal cell carcinoma.